Breaking News

PAREXEL Acquires Liquent

Expands regulatory capabilities with InSight platform

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PAREXEL International has acquired all outstanding equity securities of Liquent, Inc., a global provider of Regulatory Information Management (RIM) solutions, for approximately $72 million. Liquent provides an integrated platform of software solutions for regulatory submissions and product registration management, as well as a range of business process outsourcing capabilities. Headquartered in Horsham, PA, with additional offices in the UK, Germany and India, Liquent has nearly 300 employees.  ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters